The present disclosure relates to medical devices and systems, and more particularly, camera tracking systems used for computer assisted navigation during surgery.
A computer assisted surgery navigation system can provide a surgeon with computerized visualization of how a surgical instrument that is posed relative to a patient correlates to a pose relative to medical images of the patient's anatomy. Camera tracking systems for computer assisted surgery navigation typically use a set of cameras to track pose of a reference array on the surgical instrument, which is being positioned by a surgeon during surgery, relative to a patient reference array (also “dynamic reference base” (DRB)) affixed to a patient. The camera tracking system uses the relative poses of the reference arrays to determine how the surgical instrument is posed relative to a patient and to correlate to the surgical instrument's pose relative to the medical images of the patient's anatomy. The surgeon can thereby use real-time visual feedback of the relative poses to navigate the surgical instrument during a surgical procedure on the patient.
During the surgical procedure, a surveillance marker is affixed to the patient to provide information on whether the patient reference array has shifted. If the surveillance marker's location changes relative to the patient reference array, the camera tracking system can display a meter indicating the amount of movement and may display a pop-up warning message to inform the user that the patient reference array may have been bumped. If the patient reference array has indeed been bumped, the registration of the patient reference array to the tracked coordinate system may be invalid and could result in erroneous navigation of the surgical instrument.
In one approach, the surveillance marker is identified to the camera tracking system by pointing with a tool having a pose tracked by the camera tracking system. If the surveillance marker is to be added by a user pointing with a tool, the software waits until a stray candidate marker is within a threshold distance (e.g., defined based on pose tracking tolerance of the tool tip) for longer than a threshold amount of time (e.g., about 2 seconds) and then registers that stray candidate marker as the surveillance marker.
In another approach, the surveillance marker is identified to the tracking system by pressing a button on a display screen. If the surveillance marker is to be added from the display screen with a single button click, there can be only one stray (unregistered) candidate marker so that software of the camera tracking system can properly select the stray candidate marker for registration as the surveillance marker.
In another approach, the surveillance marker is identified to the tracking system by a user interface where the interface shows the user all the possible surveillance marker candidates and the user selects the preferred candidate by clicking on in with a touch screen or other gesture. The system may show the surveillance marker candidates to the user in different ways. One possible way to show the candidates is to provide a 3D view with icons representing each candidate and icons representing other nearby structures such as the DRB or planned screws. Another possible way to show the surveillance marker candidates is to stream a live video to the user where they can clearly see the actual physical marker, to which the user then gestures to identify.
Some embodiments of the present disclosure are directed to providing operations by the camera tracking system to improve registration of stray markers, such as a surveillance marker, when phantom markers appear in frames of tracking data from tracking cameras.
Some embodiments are directed to a camera tracking system for computer assisted navigation during surgery, which includes at least one processor that is operative to receive a stream of frames of tracking data from tracking cameras configured with a partially overlapping field-of-view. For each of a plurality of the frames in the stream, the operations identify stray markers in the frame, and identify which of the stray markers are part of a reference array. The operations designate stray markers that are part of the reference array as being assigned status, and designate stray markers that are not part of the reference array as being unknown status. For each one of the assigned status stray markers, the operations designate any other of the assigned status stray markers and any of the unknown status stray markers that are along a same epipolar line of the tracking cameras as the one of the assigned status stray markers as being epipolar ambiguous status. For each one of the epipolar ambiguous status stray markers, the operations estimate 3D locations where phantom markers can appear in the frame based on epipolar ambiguity of the tracking cameras when determining location of the one of the epipolar ambiguous status stray markers. The operations designate any of the unknown status stray markers within a threshold distance of the estimated 3D locations of the phantom markers as being phantom status, and include in a candidate registration set the unknown status stray markers that do not have phantom status.
Some embodiments are directed to a related method by a camera tracking system for computer assisted navigation during surgery. The method receives a stream of frames of tracking data from tracking cameras configured with a partially overlapping field-of-view. For each of a plurality of the frames in the stream, the method identifies stray markers in the frame, and identify which of the stray markers are part of a reference array. The method designates stray markers that are part of the reference array as being assigned status, and designates stray markers that are not part of the reference array as being unknown status. For each one of the assigned status stray markers, the method designates any other of the assigned status stray markers and any of the unknown status stray markers that are along a same epipolar line of the tracking cameras as the one of the assigned status stray markers as being epipolar ambiguous status. For each one of the epipolar ambiguous status stray markers, the method estimates 3D locations where phantom markers can appear in the frame based on epipolar ambiguity of the tracking cameras when determining location of the one of the epipolar ambiguous status stray markers. The method designates any of the unknown status stray markers within a threshold distance of the estimated 3D locations of the phantom markers as being phantom status, and includes in a candidate registration set the unknown status stray markers that do not have phantom status.
Other camera tracking system and corresponding methods and computer program products according to embodiments of the inventive subject matter will be or become apparent to one with skill in the art upon review of the following drawings and detailed description. It is intended that all such additional camera tracking system, methods. and computer program products be included within this description, be within the scope of the present inventive subject matter, and be protected by the accompanying claims. Moreover, it is intended that all embodiments disclosed herein can be implemented separately or combined in any way and/or combination.
Aspects of the present disclosure are illustrated by way of example and are not limited by the accompanying drawings. In the drawings:
It is to be understood that the present disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the description herein or illustrated in the drawings. The teachings of the present disclosure may be used and practiced in other embodiments and practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms “mounted,” “connected,” “supported,” and “coupled” and variations thereof are used broadly and encompass both direct and indirect mountings, connections, supports, and couplings. Further, “connected” and “coupled” are not restricted to physical or mechanical connections or couplings.
The following discussion is presented to enable a person skilled in the art to make and use embodiments of the present disclosure. Various modifications to the illustrated embodiments will be readily apparent to those skilled in the art, and the principles herein can be applied to other embodiments and applications without departing from embodiments of the present disclosure. Thus, the embodiments are not intended to be limited to embodiments shown, but are to be accorded the widest scope consistent with the principles and features disclosed herein. The following detailed description is to be read with reference to the figures, in which like elements in different figures have like reference numerals. The figures, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the embodiments. Skilled artisans will recognize the examples provided herein have many useful alternatives and fall within the scope of the embodiments.
Various embodiments of the present disclosure are directed to providing operations by the camera tracking system to improve registration of candidate markers, such as a surveillance marker, when phantom markers appear in frames of tracking data from tracking cameras. Before describing these embodiments is detail, various components that may be used for performing embodiments in a navigated surgery system are described with reference to
The XR headset 150 may be configured to augment a real-world scene with computer generated XR images. The XR headset 150 may be configured to provide an augmented reality (AR) viewing environment by displaying the computer generated XR images on a see-through display screen that allows light from the real-world scene to pass therethrough for combined viewing by the user. Alternatively, the XR headset 150 may be configured to provide a virtual reality (VR) viewing environment by preventing or substantially preventing light from the real-world scene from being directly viewed by the user while the user is viewing the computer-generated AR images on a display screen. The XR headset 150 can be configured to provide both AR and VR viewing environments. Thus, the term XR headset can referred to as an AR headset or a VR headset.
Referring to
The camera tracking system 200 includes tracking cameras 204 which may be spaced apart stereo cameras configured with partially overlapping field-of-views. The camera tracking system 200 can have any suitable configuration of arm(s) 202 to move, orient, and support the tracking cameras 204 in a desired location, and may contain at least one processor operable to track location of an individual marker and pose of an array of markers. As used herein, the term “pose” refers to the location (e.g., along 3 orthogonal axes) and/or the rotation angle (e.g., about the 3 orthogonal axes) of markers (e.g., DRB) relative to another marker (e.g., surveillance marker) and/or to a defined coordinate system (e.g., camera coordinate system). A pose may therefore be defined based on only the multidimensional location of the markers relative to another marker and/or relative to the defined coordinate system, based on only the multidimensional rotational angles of the markers relative to the other marker and/or to the defined coordinate system, or based on a combination of the multidimensional location and the multidimensional rotational angles. The term “pose” therefore is used to refer to location, rotational angle, or combination thereof.
The tracking cameras 204 may include, e.g., infrared cameras (e.g., bifocal or stereophotogrammetric cameras), operable to identify, for example, active and passive tracking markers for single markers (e.g., surveillance marker 500) and reference arrays which can be formed on or attached to the patient 210 (e.g., patient reference array, DRB), end effector 112 (e.g., end effector reference array), XR headset(s) 150 worn by a surgeon 120 and/or a surgical assistant 126, etc. in a given measurement volume of a camera coordinate system while viewable from the perspective of the tracking cameras 204. The tracking cameras 204 may scan the given measurement volume and detect light that is emitted or reflected from the markers in order to identify and determine locations of individual markers and poses of the reference arrays in three-dimensions. For example, active reference arrays may include infrared-emitting markers that are activated by an electrical signal (e.g., infrared light emitting diodes (LEDs)), and passive reference arrays may include retro-reflective markers that reflect infrared light (e.g., they reflect incoming IR radiation into the direction of the incoming light), for example, emitted by illuminators on the tracking cameras 204 or other suitable device.
The XR headsets 150 may each include tracking cameras (e.g., spaced apart stereo cameras) that can track location of a surveillance marker and poses of reference arrays within the XR camera headset field-of-views (FOVs) 152 and 154, respectively. Accordingly, as illustrated in
The camera tracking system 200 may operate using tracking information and other information provided by multiple XR headsets 150 such as inertial tracking information and optical tracking information (frames of tracking data). The XR headsets 150 operate to display visual information and may play-out audio information to the wearer. This information can be from local sources (e.g., the surgical robot 100 and/or other medical), remote sources (e.g., patient medical image server), and/or other electronic equipment. The camera tracking system 200 may track markers in 6 degrees-of-freedom (6DOF) relative to three axes of a 3D coordinate system and rotational angles about each axis. The XR headsets 150 may also operate to track hand poses and gestures to enable gesture-based interactions with “virtual” buttons and interfaces displayed through the XR headsets 150 and can also interpret hand or finger pointing or gesturing as various defined commands. Additionally, the XR headsets 150 may have a 1-10× magnification digital color camera sensor called a digital loupe. In some embodiments, one or more of the XR headsets 150 are minimalistic XR headsets that display local or remote information but include fewer sensors and are therefore more lightweight.
An “outside-in” machine vision navigation bar supports the tracking cameras 204 and may include a color camera. The machine vision navigation bar generally has a more stable view of the environment because it does not move as often or as quickly as the XR headsets 150 while positioned on wearers' heads. The patient reference array 116 (DRB) is generally rigidly attached to the patient with stable pitch and roll relative to gravity. This local rigid patient reference 116 can serve as a common reference for reference frames relative to other tracked arrays, such as a reference array on the end effector 112, instrument reference array 170, and reference arrays on the XR headsets 150.
During a surgical procedure using surgical navigation, the surveillance marker 500 is affixed to the patient to provide information on whether the patient reference array 116 has shifted. For example, during a spinal fusion procedure with planned placement of pedicle screw fixation, two small incisions are made over the posterior superior iliac spine bilaterally. The DRB and the surveillance marker are then affixed to the posterior superior iliac spine bilaterally. If the surveillance marker's 500 location changes relative to the patient reference array 116, the camera tracking system 200 may display a meter indicating the amount of movement and/or may display a pop-up warning message to inform the user that the patient reference array may have been bumped. If the patient reference array has indeed been bumped, the registration of the patient reference array to the tracked coordinate system may be invalid and could result in erroneous navigation which is off target.
When present, the surgical robot (also “robot”) may be positioned near or next to patient 210. The robot 100 can be positioned at any suitable location near the patient 210 depending on the area of the patient 210 undergoing the surgical procedure. The camera tracking system 200 may be separated from the robot system 100 and positioned at the foot of patient 210. This location allows the tracking camera 200 to have a direct visual line of sight to the surgical area 208. In the configuration shown, the surgeon 120 may be positioned across from the robot 100, but is still able to manipulate the end-effector 112 and the display 110. A surgical assistant 126 may be positioned across from the surgeon 120 again with access to both the end-effector 112 and the display 110. If desired, the locations of the surgeon 120 and the assistant 126 may be reversed. An anesthesiologist 122, nurse or scrub tech can operate equipment which may be connected to display information from the camera tracking system 200 on a display 34.
With respect to the other components of the robot 100, the display 110 can be attached to the surgical robot 100 or in a remote location. End-effector 112 may be coupled to the robot arm 104 and controlled by at least one motor. In some embodiments, end-effector 112 can comprise a guide tube 114, which is configured to receive and orient a surgical instrument, tool, or implant used to perform a surgical procedure on the patient 210.
As used herein, the term “end-effector” is used interchangeably with the terms “end-effectuator” and “effectuator element.” The term “instrument” is used in a non-limiting manner and can be used interchangeably with “tool” and “implant” to generally refer to any type of device that can be used during a surgical procedure in accordance with embodiments disclosed herein. Example instruments, tools, and implants include, without limitation, drills, screwdrivers, saws, dilators, retractors, probes, implant inserters, and implant devices such as a screws, spacers, interbody fusion devices, plates, rods, etc. Although generally shown with a guide tube 114, it will be appreciated that the end-effector 112 may be replaced with any suitable instrumentation suitable for use in surgery. In some embodiments, end-effector 112 can comprise any known structure for effecting the movement of the surgical instrument in a desired manner.
The surgical robot 100 is operable to control the translation and orientation of the end-effector 112. The robot 100 may move the end-effector 112 under computer control along x-, y-, and z-axes, for example. The end-effector 112 can be configured for selective rotation about one or more of the x-, y-, and z-axis, and a Z Frame axis, such that one or more of the Euler Angles (e.g., roll, pitch, and/or yaw) associated with end-effector 112 can be selectively computer controlled. In some embodiments, selective control of the translation and orientation of end-effector 112 can permit performance of medical procedures with significantly improved accuracy compared to conventional robots that utilize, for example, a six DOF robot arm comprising only rotational axes. For example, the surgical robot 100 may be used to operate on patient 210, and robot arm 104 can be positioned above the body of patient 210, with end-effector 112 selectively angled relative to the z-axis toward the body of patient 210.
In some example embodiments, the XR headsets 150 can be controlled to dynamically display an updated graphical indication of the pose of the surgical instrument so that the user can be aware of the pose of the surgical instrument at all times during the procedure.
In some further embodiments, surgical robot 100 can be operable to correct the path of a surgical instrument guided by the robot arm 104 if the surgical instrument strays from the selected, preplanned trajectory. The surgical robot 100 can be operable to permit stoppage, modification, and/or manual control of the movement of end-effector 112 and/or the surgical instrument. Thus, in use, a surgeon or other user can use the surgical robot 100 as part of computer assisted navigated surgery, and has the option to stop, modify, or manually control the autonomous or semi-autonomous movement of the end-effector 112 and/or the surgical instrument.
Reference arrays of markers can be formed on or connected to robot arms 102 and/or 104, the end-effector 112 (e.g., end-effector array 114 in
Referring to
In computer-assisted navigated surgeries, perpendicular 2D scan slices, such as axial, sagittal, and/or coronal views, of patient anatomical structure are displayed to enable user visualization of the patient's anatomy alongside the relative poses of surgical instruments. An XR headset or other display can be controlled to display one or more 2D scan slices of patient anatomy along with a 3D graphical model of anatomy. The 3D graphical model may be generated from a 3D scan of the patient, e.g., by a CT scan device, and/or may be generated based on a baseline model of anatomy which isn't necessarily formed from a scan of the patient.
Example Surgical System:
The imaging devices 420 may include a C-arm imaging device, an O-arm imaging device, and/or a patient image database. The XR headset 150 provides an improved human interface for performing navigated surgical procedures. The XR headset 150 can be configured to provide functionalities, e.g., via the computer platform 400, that include without limitation any one or more of: identification of hand gesture based commands, display XR graphical objects on a display device 438 of the XR headset 150 and/or another display device. The display device 438 may include a video projector, flat panel display, etc. The user may view the XR graphical objects as an overlay anchored to particular real-world objects viewed through a see-through display screen. The XR headset 150 may additionally or alternatively be configured to display on the display device 438 video streams from cameras mounted to one or more XR headsets 150 and other cameras.
Electrical components of the XR headset 150 can include a plurality of cameras 430, a microphone 432, a gesture sensor 434, a pose sensor (e.g., inertial measurement unit (IMU)) 436, the display device 438, and a wireless/wired communication interface 440. The cameras 430 of the XR headset 150 may be visible light capturing cameras, near infrared capturing cameras, or a combination of both.
The cameras 430 may be configured to operate as the gesture sensor 434 by tracking for identification user hand gestures performed within the field of view of the camera(s) 430. Alternatively, the gesture sensor 434 may be a proximity sensor and/or a touch sensor that senses hand gestures performed proximately to the gesture sensor 434 and/or senses physical contact, e.g., tapping on the sensor 434 or its enclosure. The pose sensor 436, e.g., IMU, may include a multi-axis accelerometer, a tilt sensor, and/or another sensor that can sense rotation and/or acceleration of the XR headset 150 along one or more defined coordinate axes. Some or all of these electrical components may be contained in a head-worn component enclosure or may be contained in another enclosure configured to be worn elsewhere, such as on the hip or shoulder.
As explained above, a surgical system includes the camera tracking system 200 which may be connected to a computer platform 400 for operational processing and which may provide other operational functionality including a navigation controller 404 and/or of an XR headset controller 410. The surgical system may include the surgical robot 100. The navigation controller 404 can be configured to provide visual navigation guidance to an operator for moving and positioning a surgical tool relative to patient anatomical structure based on a surgical plan, e.g., from a surgical planning function, defining where a surgical procedure is to be performed using the surgical tool on the anatomical structure and based on a pose of the anatomical structure determined by the camera tracking system 200. The navigation controller 404 may be further configured to generate navigation information based on a target pose for a surgical tool, a pose of the anatomical structure, and a pose of the surgical tool and/or an end effector of the surgical robot 100, where the steering information is displayed through the display device 438 of the XR headset 150 and/or another display device to indicate where the surgical tool and/or the end effector of the surgical robot 100 should be moved to perform the surgical plan.
The electrical components of the XR headset 150 can be operatively connected to the electrical components of the computer platform 400 through the wired/wireless interface 440. The electrical components of the XR headset 150 may be operatively connected, e.g., through the computer platform 400 or directly connected, to various imaging devices 420, e.g., the C-arm imaging device, the I/O-arm imaging device, the patient image database, and/or to other medical equipment through the wired/wireless interface 440.
The surgical system may include a XR headset controller 410 that may at least partially reside in the XR headset 150, the computer platform 400, and/or in another system component connected via wired cables and/or wireless communication links. Various functionality is provided by software executed by the XR headset controller 410. The XR headset controller 410 is configured to receive information from the camera tracking system 200 and the navigation controller 404, and to generate an XR image based on the information for display on the display device 438.
The XR headset controller 410 can be configured to operationally process frames of tracking data from tracking cameras from the cameras 430 (tracking cameras), signals from the microphone 1620, and/or information from the pose sensor 436 and the gesture sensor 434, to generate information for display as XR images on the display device 438 and/or as other for display on other display devices for user viewing. Thus, the XR headset controller 410 illustrated as a circuit block within the XR headset 150 is to be understood as being operationally connected to other illustrated components of the XR headset 150 but not necessarily residing within a common housing or being otherwise transportable by the user. For example, the XR headset controller 410 may reside within the computer platform 400 which, in turn, may reside within the cabinet 330 of the camera tracking system 200, the cabinet 106 of the surgical robot 100, etc.
Identifying Phantom Markers Imaged by Tracking Cameras:
Regardless of the workflow for registering a stray maker, such as the surveillance marker, the presence of “phantom” markers can be problematic. Phantom markers occur as a result of epipolar stereo tracking ambiguity, reflections and other environmental conditions, and do not represent the 3D location of a stray actual marker. A stray actual marker is a physical marker, e.g., surveillance marker, that appears in frames of tracking data from tracking cameras and is intended to be tracked by the camera tracking system, but which has not yet been registered with the camera tracking system. If a phantom marker also appears in the frames, the presence of the phantom markers can make it infeasible to register the stray actual marker with just a single button press, because the system does not know which of the marker candidates to use. The camera tracking system also becomes susceptible to error if, for example, the actual marker is not present (e.g., obscured from view) while only one phantom is present in the frames, which can cause the single button press to trigger incorrect registration of the phantom marker as the actual marker. Alternatively, if the user happens to accidentally point a tracked tool at a point in space where a phantom marker is closer to the tip than the stray actual marker or inadvertently gesture to identify a phantom adjacent to the intended candidate, the camera tracking system could incorrectly register the phantom marker as the actual marker.
As explained above, various embodiments of the present disclosure are directed to providing operations by the camera tracking system 200 which may improve registration of stray markers, such as the surveillance marker 500 in
Some embodiments are directed to operations which classify stray markers as “assigned” status, “unknown” status, and/or “phantom” status in a frame of tracking data from tracking cameras on a tracking bar, XR headset, etc. Stray markers may be filtered so that registration is only performed on a stray marker which does not have phantom status, such as when a user registers a surveillance marker. By eliminating any phantom status strays being used in the registration process, the operations may increase the incidence of scenarios where the surveillance marker can be selected through a user interface, e.g., by a user-selectable registration button, instead of requiring tracking of a user-posed pointing tool and which can avoid or prevent various errors such as described above. These operations may utilize the inconsistent visibility and location of phantoms markers versus actual stray markers.
In some embodiments, both the patient reference array (e.g., DRB) and surveillance marker are viewed from more than one perspective of the tracking cameras, e.g., arranged in a stereo configuration with partially overlapping field-of-view. More than one perspective can be obtained by moving the tracking cameras to provide rotational and/or linear location offset between frames of tracking data received from the tracking cameras. In one scenario, a user affixes a DRB and a surveillance marker to the patient and then moves the tracking cameras on a camera bar to provide more optimal positioning for tracking of markers during a surgical procedure. While the tracking cameras are being moved and the surveillance marker and DRB are visible, operations are performed to identify candidate markers in frames of tracking data from the tracking cameras, and to process the candidate markers into various different statuses, which are referred to without limitation as, e.g., assigned status, unknown status, and ambiguous status.
In one operational embodiment, when a frame is received from the tracking cameras, the position of the DRB in the camera coordinate system is recorded along with all stray makers (also “strays”) visible from this perspective of the tracking cameras. For easier comparison to other frames, locations of stray markers are recorded relative to the DRB, not in the camera coordinate system in accordance with one embodiment. Next, the set of previous camera positions and the corresponding sets of stray markers are compared to the current frame. If the current camera orientation for a received frame is the same (e.g., within a tolerance threshold, such as less than 10 mm or 1 degree) as a previous camera orientation for a previously received frame, the stray markers from the stored set are compared to the previous set for this orientation and any stray markers now present that were not present previously are included in a set for further processing and stored. This operation accounts for actual stray markers that may have been blocked from line of sight in a previous frame. If this camera orientation is different than any previous orientation (e.g., more than the tolerance threshold), any stray markers common to both sets (e.g., difference in position relative to DRB<1 mm) can be classified with unknown status for further processing to determine whether they should be designated as phantom status, while any candidate markers not common to both sets may be more likely to be phantom and may not be included in further processing or may be processed to have an increased likelihood of being designated as phantom status. As the tracking cameras continue to move and more orientations are recorded, their respective sets of stray markers are compared to the sets of stray markers for all other orientations. In some embodiment, only stray markers that are present in greater than some minimum number of orientations are included in a candidate registration set which is used to perform registration of one or more markers in the set. With these operations, it is possible for stray markers to have status changed from unknown to phantom or vice versa depending on in how many different tracking camera orientations they were identified in the corresponding received frames.
The operation for changing stray markers' status, based on how many frames from different tracking camera orientations they are identified in, can be directed to situations where phantom markers are identified in frames from more than one tracking camera perspective by chance and where there may be frames where the actual stray markers are obscured or not visible to the tracking cameras for some reason. It would be undesirable for such frames to cause the actual stray markers to inadvertently be designated as phantom strays thereafter.
Some further embodiments are directed to identifying phantom markers that can arise specifically from epipolar ambiguity of the tracking cameras when determining locations of actual stray markers, such as a surveillance marker.
Referring to
For each one of the assigned status stray markers, the operations designate 606 any other of the assigned status stray markers and any of the unknown status stray markers that are along a same epipolar line of the tracking cameras as the one of the assigned status stray markers as being epipolar ambiguous status. For each one of the epipolar ambiguous status stray markers, the operations estimate 608 3D locations where phantom markers can appear in the frame based on epipolar ambiguity of the tracking cameras when determining location of the one of the epipolar ambiguous status stray markers. The operations designate 610 any of the unknown status stray markers within a threshold distance of the estimated 3D locations of the phantom markers as being phantom status, and include 612 in a candidate registration set the unknown status stray markers that do not have phantom status.
The threshold distance value may be a function of the epipolar ambiguity of the tracking cameras. In some embodiments, the threshold distance is not greater than 2 millimeters so that, for example, if a unknown status stray markers is within a 2 millimeter cubic box centered at the computed 3D location of the phantom marker, that unknown status stray marker is designated 610 as phantom status.
The operations may further perform registration of one or more of the unknown status stray markers in the candidate registration set. For example, as will be explained in further detail below, when only one unknown status stray marker exists in the candidate registration set, the camera tracking system may display a registration indicia that can be selected by a user to register the unknown status stray marker as a surveillance marker or another defined marker.
Because phantom markers should not be allowed to be registered, the operations may prevent registration of any of the phantom status stray markers.
The camera tracking system may operate to track location of the registered one of the unknown status stray markers relative to the reference array. For example, the operations may track location of the surveillance marker relative to the DRB to determine if the DRB and/or the surveillance marker has moved, such as from being bumped by a user, and may trigger a warning notification to be generated to the user of a threshold movement is identified.
The operations may limit registration 614 to being performed on only unknown status stray markers that are identified in at least a threshold number of the plurality of frames. The operations may further limit registration 614 to being performed on only unknown status stray markers that are identified in at least the threshold number of the plurality of frames which have been determined to have camera movement offsets greater than a threshold movement offset.
The operations may determine a movement offset of the tracking cameras between receipt of the present frame and receipt of a previous frame or, in a further embodiment, receipt of any of the previously received frames. Thus, the “previous frame” may be the frame received in sequence immediately before the present frame or may be any of the frames that were received in the stream before the present frame. The determination of the movement offset may include determining a rotational offset of the tracking cameras and/or a linear location offset of the tracking cameras.
The threshold movement offset may be, for example, defined as more than 10 millimeters of linear location offset of the tracking cameras and/or defined as more than one degree of rotational offset of the tracking cameras between capturing the present frame and capturing a previous frame. The movement offset may be determined based on comparing the 3D locations of the candidate markers of the present frame set to the 3D locations of the candidate markers of the previous frame set or, in some embodiments, to the 3D locations of the candidate markers in any of the frame sets that were identified from earlier frames in the stream. The decision of whether the movement offset is less than the threshold movement offset, may include comparing the 3D locations of the candidate markers of the present frame set to the 3D locations of the candidate markers of any of the previously received frame sets in order to, for example, determine whether the present orientation of the tracking cameras is not sufficiently different from an earlier orientation of the tracking cameras.
In one embodiment, the operations determine 3D locations of the stray markers, determine a camera movement offset of the tracking cameras between receipt of the frame and receipt of a previous frame, and based on when the camera movement offset is less than a threshold movement offset, not perform the estimation 608 of 3D locations where phantom markers can appear in the frame based on epipolar ambiguity of the tracking cameras. For example, the operations may wait for the camera movement offset to be at least the threshold movement offset before processing a next frame to perform operations 608-612.
Example Registration Operations:
Some further embodiments are directed to utilizing the operations of
For example, after unknown status stray markers that do not have phantom status have been identified (included 612 in the candidate registration set), the operations may generate a user interface through which a user provides at least one command to cause registration 614 of those stray markers for location tracking by the camera tracking system. The operation may then enable tracking of the location of the one of the candidate markers as a surveillance marker tracked relative to a reference array.
For example, when the candidate registration set contains a single candidate marker, e.g., a single unknown status stray marker that do not have phantom status, the operations may display a user-selectable indicia that can be selected by a user to trigger registration of the candidate marker as a surveillance marker. Because the surveillance marker should be positioned relatively closely to a DRB in order to allow tracking of any movement of the DRB and/or surveillance marker, e.g., due to being bumped, the operations may require that single single unknown status stray marker without phantom status to be within a threshold distance of the DRB or another defined reference array before displaying the user-selectable indicia allowing the user to trigger registration of that stray marker as a surveillance marker. The threshold distance from the DRB or other defined reference array may be, for example, less than 30 centimeters, in accordance with some embodiments.
For example, in one embodiment, the camera tracking system determines a particular one of the stray markers included in the candidate registration set satisfies a defined rule for corresponding to a surveillance marker such as by being the only stray marker in the candidate registration set. The camera tracking system can respond to the determination by displaying a registration initiation indicia selected by a user to trigger registration of the particular one of the stray markers as the surveillance marker. Once registration of the stray marker as the surveillance marker is complete, the camera tracking system can then track location of the surveillance marker relative to the DRB or other reference array. In a further embodiment, to satisfy the defined rule the particular one of the candidate markers included in the candidate registration set needs to be determined to be within a threshold distance from the reference array. As explained above, Because the surveillance marker should be positioned relatively closely to a DRB in order to allow tracking of any movement of the DRB and/or surveillance marker, e.g., due to being bumped, the operations may require the single stray marker to be within a threshold distance of the DRB or another defined reference array before displaying the user-selectable indicia allowing the user to trigger registration of the stray marker as a surveillance marker. The threshold distance from the DRB or other defined reference array may be, for example, less than 30 centimeters, in accordance with some embodiments.
The camera tracking system may display visual cues to a user to facilitate involvement in some of the operations described in
In one embodiments, as part of operations of
The camera tracking system may provide guidance to a user to begin and/or end movement of the tracking cameras to facilitate registration and tracking of markers. For example, in one embodiment, the system displays an indication to a user that further movement of the tracking cameras is not needed for registration, responsive to determining that the stray marker(s) included in the candidate registration set satisfies a defined rule. The defined rule may correspond to determining that the stray marker(s) have been present in at least a threshold number of previous frames, may further include determining that those threshold number of previous frames have at least a threshold offset relative to each other.
In some other embodiments, the camera tracking system may determine locations of the the unknown status stray markers, and display graphical indications overlaid on at least one of the frames at the locations of the unknown status stray markers. The graphical indications may be overlaid at locations in at least one of the frames determined based on the determined 3D locations. The operations receive a user selection of one of the graphical indications, and perform registration of one of the unknown status stray markers with the location corresponding to the selected one of the graphical indications.
The operations may receive the user selection of one of the graphical indications through a touch screen interface, such as by the user touch-selecting one of the graphical indications to register the one of the unknown status stray markers with the location corresponding to the selected one of the graphical indications.
Alternatively or additionally, the operations may display a graphical representation of a tool being tracked by the camera tracking system while the tool is manipulated by the user. The operations receive the user selection of the one of the graphical indications based on determining a tracked location on the tool is within a threshold selection distance from the location of the one of the graphical indications while a further defined condition is satisfied. Thus, for example, the user can indicate which of the stray markers is to be registered as the surveillance marker by positioning an end of the displayed graphically representation of the tool within the threshold selection distance of the displayed graphical indication associated with the to-be-selected stray marker.
As explained above, once the stray marker(s) are registered with the camera tracking system, the camera tracking system may then perform operations for navigated surgical procedures. The operations can include to track pose of an instrument relative to the registered marker, and generate steering information based on comparison of the pose of the instrument relative to a planned pose of the instrument. The steering information can indicate where the instrument needs to be moved and angularly oriented to become aligned with the planned pose when performing a surgical procedure.
Another embodiment for a method to eliminate stray markers from consideration is to assess whether the marker is located in an untenable place. For example, does the stray maker appear to be on the surface of the robot arm, inside the patient, or on the bed? If so, it is most likely a phantom stray and can be eliminated from the set of candidates, e.g., not included in the candidate registration set. Position of a stray marker relative to the robot or patient requires knowledge of the location of these other structures. Because the robot arm is tracked and can have position sensors in each joint, the operations may compute the location of the arm surface based on these tracked parameters and compare locations of the surfaces of the robot arm to locations of each stray marker. To determine whether a tracked location is inside the patient, the operations may use the registration of the CT scan volume to the tracking cameras and to use planned implant locations, image processing, machine vision, or a manual identification of surface points to compute where the patient is positioned relative to the cameras.
In the above-description of various embodiments of present inventive concepts, it is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of present inventive concepts. Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which present inventive concepts belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of this specification and the relevant art and will not be interpreted in an idealized or overly formal sense expressly so defined herein.
When an element is referred to as being “connected”, “coupled”, “responsive”, or variants thereof to another element, it can be directly connected, coupled, or responsive to the other element or intervening elements may be present. In contrast, when an element is referred to as being “directly connected”, “directly coupled”, “directly responsive”, or variants thereof to another element, there are no intervening elements present. Like numbers refer to like elements throughout. Furthermore, “coupled”, “connected”, “responsive”, or variants thereof as used herein may include wirelessly coupled, connected, or responsive. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. Well-known functions or constructions may not be described in detail for brevity and/or clarity. The term “and/or” includes any and all combinations of one or more of the associated listed items.
It will be understood that although the terms first, second, third, etc. may be used herein to describe various elements/operations, these elements/operations should not be limited by these terms. These terms are only used to distinguish one element/operation from another element/operation. Thus, a first element/operation in some embodiments could be termed a second element/operation in other embodiments without departing from the teachings of present inventive concepts. The same reference numerals or the same reference designators denote the same or similar elements throughout the specification.
As used herein, the terms “comprise”, “comprising”, “comprises”, “include”, “including”, “includes”, “have”, “has”, “having”, or variants thereof are open-ended, and include one or more stated features, integers, elements, steps, components or functions but does not preclude the presence or addition of one or more other features, integers, elements, steps, components, functions or groups thereof. Furthermore, as used herein, the common abbreviation “e.g.”, which derives from the Latin phrase “exempli gratia,” may be used to introduce or specify a general example or examples of a previously mentioned item, and is not intended to be limiting of such item. The common abbreviation “i.e.”, which derives from the Latin phrase “id est,” may be used to specify a particular item from a more general recitation.
Example embodiments are described herein with reference to block diagrams and/or flowchart illustrations of computer-implemented methods, apparatus (systems and/or devices) and/or computer program products. It is understood that a block of the block diagrams and/or flowchart illustrations, and combinations of blocks in the block diagrams and/or flowchart illustrations, can be implemented by computer program instructions that are performed by one or more computer circuits. These computer program instructions may be provided to a processor circuit of a general purpose computer circuit, special purpose computer circuit, and/or other programmable data processing circuit to produce a machine, such that the instructions, which execute via the processor of the computer and/or other programmable data processing apparatus, transform and control transistors, values stored in memory locations, and other hardware components within such circuitry to implement the functions/acts specified in the block diagrams and/or flowchart block or blocks, and thereby create means (functionality) and/or structure for implementing the functions/acts specified in the block diagrams and/or flowchart block(s).
These computer program instructions may also be stored in a tangible computer-readable medium that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable medium produce an article of manufacture including instructions which implement the functions/acts specified in the block diagrams and/or flowchart block or blocks. Accordingly, embodiments of present inventive concepts may be embodied in hardware and/or in software (including firmware, resident software, micro-code, etc.) that runs on a processor such as a digital signal processor, which may collectively be referred to as “circuitry,” “a module” or variants thereof.
It should also be noted that in some alternate implementations, the functions/acts noted in the blocks may occur out of the order noted in the flowcharts. For example, two blocks shown in succession may in fact be executed substantially concurrently or the blocks may sometimes be executed in the reverse order, depending upon the functionality/acts involved. Moreover, the functionality of a given block of the flowcharts and/or block diagrams may be separated into multiple blocks and/or the functionality of two or more blocks of the flowcharts and/or block diagrams may be at least partially integrated. Finally, other blocks may be added/inserted between the blocks that are illustrated, and/or blocks/operations may be omitted without departing from the scope of inventive concepts. Moreover, although some of the diagrams include arrows on communication paths to show a primary direction of communication, it is to be understood that communication may occur in the opposite direction to the depicted arrows.
Many variations and modifications can be made to the embodiments without substantially departing from the principles of the present inventive concepts. All such variations and modifications are intended to be included herein within the scope of present inventive concepts. Accordingly, the above disclosed subject matter is to be considered illustrative, and not restrictive, and the appended examples of embodiments are intended to cover all such modifications, enhancements, and other embodiments, which fall within the spirit and scope of present inventive concepts. Thus, to the maximum extent allowed by law, the scope of present inventive concepts are to be determined by the broadest permissible interpretation of the present disclosure including the following examples of embodiments and their equivalents, and shall not be restricted or limited by the foregoing detailed description.
Number | Name | Date | Kind |
---|---|---|---|
4150293 | Franke | Apr 1979 | A |
5246010 | Gazzara et al. | Sep 1993 | A |
5354314 | Hardy et al. | Oct 1994 | A |
5397323 | Taylor et al. | Mar 1995 | A |
5598453 | Baba et al. | Jan 1997 | A |
5772594 | Barrick | Jun 1998 | A |
5791908 | Gillio | Aug 1998 | A |
5820559 | Ng et al. | Oct 1998 | A |
5825982 | Wright et al. | Oct 1998 | A |
5887121 | Funda et al. | Mar 1999 | A |
5911449 | Daniele et al. | Jun 1999 | A |
5951475 | Gueziec et al. | Sep 1999 | A |
5987960 | Messner et al. | Nov 1999 | A |
6012216 | Esteves et al. | Jan 2000 | A |
6031888 | Ivan et al. | Feb 2000 | A |
6033415 | Mittelstadt et al. | Mar 2000 | A |
6080181 | Jensen et al. | Jun 2000 | A |
6106511 | Jensen | Aug 2000 | A |
6122541 | Cosman et al. | Sep 2000 | A |
6144875 | Schweikard et al. | Nov 2000 | A |
6157853 | Blume et al. | Dec 2000 | A |
6167145 | Foley et al. | Dec 2000 | A |
6167292 | Badano et al. | Dec 2000 | A |
6201984 | Funda et al. | Mar 2001 | B1 |
6203196 | Meyer et al. | Mar 2001 | B1 |
6205411 | DiGioia, III et al. | Mar 2001 | B1 |
6212419 | Blume et al. | Apr 2001 | B1 |
6231565 | Tovey et al. | May 2001 | B1 |
6236875 | Bucholz et al. | May 2001 | B1 |
6246900 | Cosman et al. | Jun 2001 | B1 |
6301495 | Gueziec et al. | Oct 2001 | B1 |
6306126 | Montezuma | Oct 2001 | B1 |
6312435 | Wallace et al. | Nov 2001 | B1 |
6314311 | Williams et al. | Nov 2001 | B1 |
6320929 | Von Der Haar | Nov 2001 | B1 |
6322567 | Mittelstadt et al. | Nov 2001 | B1 |
6325808 | Bernard et al. | Dec 2001 | B1 |
6340363 | Bolger et al. | Jan 2002 | B1 |
6377011 | Ben-Ur | Apr 2002 | B1 |
6379302 | Kessman et al. | Apr 2002 | B1 |
6402762 | Hunter et al. | Jun 2002 | B2 |
6424885 | Niemeyer et al. | Jul 2002 | B1 |
6447503 | Wynne et al. | Sep 2002 | B1 |
6451027 | Cooper et al. | Sep 2002 | B1 |
6477400 | Barrick | Nov 2002 | B1 |
6484049 | Seeley et al. | Nov 2002 | B1 |
6487267 | Wolter | Nov 2002 | B1 |
6490467 | Bucholz et al. | Dec 2002 | B1 |
6490475 | Seeley et al. | Dec 2002 | B1 |
6499488 | Hunter et al. | Dec 2002 | B1 |
6501981 | Schweikard et al. | Dec 2002 | B1 |
6507751 | Blume et al. | Jan 2003 | B2 |
6535756 | Simon et al. | Mar 2003 | B1 |
6560354 | Maurer, Jr. et al. | May 2003 | B1 |
6565554 | Niemeyer | May 2003 | B1 |
6587750 | Gerbi et al. | Jul 2003 | B2 |
6614453 | Suri et al. | Sep 2003 | B1 |
6614871 | Kobiki et al. | Sep 2003 | B1 |
6619840 | Rasche et al. | Sep 2003 | B2 |
6636757 | Jascob et al. | Oct 2003 | B1 |
6645196 | Nixon et al. | Nov 2003 | B1 |
6666579 | Jensen | Dec 2003 | B2 |
6669635 | Kessman et al. | Dec 2003 | B2 |
6701173 | Nowinski et al. | Mar 2004 | B2 |
6757068 | Foxlin | Jun 2004 | B2 |
6782287 | Grzeszczuk et al. | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6786896 | Madhani et al. | Sep 2004 | B1 |
6788018 | Blumenkranz | Sep 2004 | B1 |
6804581 | Wang et al. | Oct 2004 | B2 |
6823207 | Jensen et al. | Nov 2004 | B1 |
6827351 | Graziani et al. | Dec 2004 | B2 |
6837892 | Shoham | Jan 2005 | B2 |
6839612 | Sanchez et al. | Jan 2005 | B2 |
6856826 | Seeley et al. | Feb 2005 | B2 |
6856827 | Seeley et al. | Feb 2005 | B2 |
6879880 | Nowlin et al. | Apr 2005 | B2 |
6892090 | Verard et al. | May 2005 | B2 |
6920347 | Simon et al. | Jul 2005 | B2 |
6922632 | Foxlin | Jul 2005 | B2 |
6968224 | Kessman et al. | Nov 2005 | B2 |
6978166 | Foley et al. | Dec 2005 | B2 |
6988009 | Grimm et al. | Jan 2006 | B2 |
6991627 | Madhani et al. | Jan 2006 | B2 |
6996487 | Jutras et al. | Feb 2006 | B2 |
6999852 | Green | Feb 2006 | B2 |
7007699 | Martinelli et al. | Mar 2006 | B2 |
7016457 | Senzig et al. | Mar 2006 | B1 |
7043961 | Pandey et al. | May 2006 | B2 |
7062006 | Pelc et al. | Jun 2006 | B1 |
7063705 | Young et al. | Jun 2006 | B2 |
7072707 | Galloway, Jr. et al. | Jul 2006 | B2 |
7083615 | Peterson et al. | Aug 2006 | B2 |
7097640 | Wang et al. | Aug 2006 | B2 |
7099428 | Clinthorne et al. | Aug 2006 | B2 |
7108421 | Gregerson et al. | Sep 2006 | B2 |
7130676 | Barrick | Oct 2006 | B2 |
7139418 | Abovitz et al. | Nov 2006 | B2 |
7139601 | Bucholz et al. | Nov 2006 | B2 |
7155316 | Sutherland et al. | Dec 2006 | B2 |
7164968 | Treat et al. | Jan 2007 | B2 |
7167738 | Schweikard et al. | Jan 2007 | B2 |
7169141 | Brock et al. | Jan 2007 | B2 |
7172627 | Fiere et al. | Feb 2007 | B2 |
7194120 | Wicker et al. | Mar 2007 | B2 |
7197107 | Arai et al. | Mar 2007 | B2 |
7231014 | Levy | Jun 2007 | B2 |
7231063 | Naimark et al. | Jun 2007 | B2 |
7239940 | Wang et al. | Jul 2007 | B2 |
7248914 | Hastings et al. | Jul 2007 | B2 |
7301648 | Foxlin | Nov 2007 | B2 |
7302288 | Schellenberg | Nov 2007 | B1 |
7313430 | Urquhart et al. | Dec 2007 | B2 |
7318805 | Schweikard et al. | Jan 2008 | B2 |
7318827 | Leitner et al. | Jan 2008 | B2 |
7319897 | Leitner et al. | Jan 2008 | B2 |
7324623 | Heuscher et al. | Jan 2008 | B2 |
7327865 | Fu et al. | Feb 2008 | B2 |
7331967 | Lee et al. | Feb 2008 | B2 |
7333642 | Green | Feb 2008 | B2 |
7339341 | Oleynikov et al. | Mar 2008 | B2 |
7366562 | Dukesherer et al. | Apr 2008 | B2 |
7379790 | Toth et al. | May 2008 | B2 |
7386365 | Nixon | Jun 2008 | B2 |
7422592 | Morley et al. | Sep 2008 | B2 |
7435216 | Kwon et al. | Oct 2008 | B2 |
7440793 | Chauhan et al. | Oct 2008 | B2 |
7460637 | Clinthorne et al. | Dec 2008 | B2 |
7466303 | Yi et al. | Dec 2008 | B2 |
7493153 | Ahmed et al. | Feb 2009 | B2 |
7505617 | Fu et al. | Mar 2009 | B2 |
7533892 | Schena et al. | May 2009 | B2 |
7542791 | Mire et al. | Jun 2009 | B2 |
7555331 | Viswanathan | Jun 2009 | B2 |
7567834 | Clayton et al. | Jul 2009 | B2 |
7594912 | Cooper et al. | Sep 2009 | B2 |
7606613 | Simon et al. | Oct 2009 | B2 |
7607440 | Coste-Maniere et al. | Oct 2009 | B2 |
7623902 | Pacheco | Nov 2009 | B2 |
7630752 | Viswanathan | Dec 2009 | B2 |
7630753 | Simon et al. | Dec 2009 | B2 |
7643862 | Schoenefeld | Jan 2010 | B2 |
7660623 | Hunter et al. | Feb 2010 | B2 |
7661881 | Gregerson et al. | Feb 2010 | B2 |
7683331 | Chang | Mar 2010 | B2 |
7683332 | Chang | Mar 2010 | B2 |
7689320 | Prisco et al. | Mar 2010 | B2 |
7691098 | Wallace et al. | Apr 2010 | B2 |
7702379 | Avinash et al. | Apr 2010 | B2 |
7702477 | Tuemmler et al. | Apr 2010 | B2 |
7711083 | Heigl et al. | May 2010 | B2 |
7711406 | Kuhn et al. | May 2010 | B2 |
7720523 | Omernick et al. | May 2010 | B2 |
7725253 | Foxlin | May 2010 | B2 |
7726171 | Langlotz et al. | Jun 2010 | B2 |
7742801 | Neubauer et al. | Jun 2010 | B2 |
7751865 | Jascob et al. | Jul 2010 | B2 |
7760849 | Zhang | Jul 2010 | B2 |
7762825 | Burbank et al. | Jul 2010 | B2 |
7763015 | Cooper et al. | Jul 2010 | B2 |
7787699 | Mahesh et al. | Aug 2010 | B2 |
7796728 | Bergfjord | Sep 2010 | B2 |
7813838 | Sommer | Oct 2010 | B2 |
7818044 | Dukesherer et al. | Oct 2010 | B2 |
7819859 | Prisco et al. | Oct 2010 | B2 |
7824401 | Manzo et al. | Nov 2010 | B2 |
7831294 | Viswanathan | Nov 2010 | B2 |
7834484 | Sartor | Nov 2010 | B2 |
7835557 | Kendrick et al. | Nov 2010 | B2 |
7835778 | Foley et al. | Nov 2010 | B2 |
7835784 | Mire et al. | Nov 2010 | B2 |
7840253 | Tremblay et al. | Nov 2010 | B2 |
7840256 | Lakin et al. | Nov 2010 | B2 |
7843158 | Prisco | Nov 2010 | B2 |
7844320 | Shahidi | Nov 2010 | B2 |
7853305 | Simon et al. | Dec 2010 | B2 |
7853313 | Thompson | Dec 2010 | B2 |
7865269 | Prisco et al. | Jan 2011 | B2 |
D631966 | Perloff et al. | Feb 2011 | S |
7879045 | Gielen et al. | Feb 2011 | B2 |
7881767 | Strommer et al. | Feb 2011 | B2 |
7881770 | Melkent et al. | Feb 2011 | B2 |
7886743 | Cooper et al. | Feb 2011 | B2 |
RE42194 | Foley et al. | Mar 2011 | E |
RE42226 | Foley et al. | Mar 2011 | E |
7900524 | Calloway et al. | Mar 2011 | B2 |
7907166 | Lamprecht et al. | Mar 2011 | B2 |
7909122 | Schena et al. | Mar 2011 | B2 |
7925653 | Saptharishi | Apr 2011 | B2 |
7930065 | Larkin et al. | Apr 2011 | B2 |
7935130 | Williams | May 2011 | B2 |
7940999 | Liao et al. | May 2011 | B2 |
7945012 | Ye et al. | May 2011 | B2 |
7945021 | Shapiro et al. | May 2011 | B2 |
7953470 | Vetter et al. | May 2011 | B2 |
7954397 | Choi et al. | Jun 2011 | B2 |
7971341 | Dukesherer et al. | Jul 2011 | B2 |
7974674 | Hauck et al. | Jul 2011 | B2 |
7974677 | Mire et al. | Jul 2011 | B2 |
7974681 | Wallace et al. | Jul 2011 | B2 |
7979157 | Anvari | Jul 2011 | B2 |
7983733 | Viswanathan | Jul 2011 | B2 |
7988215 | Seibold | Aug 2011 | B2 |
7996110 | Lipow et al. | Aug 2011 | B2 |
8004121 | Sartor | Aug 2011 | B2 |
8004229 | Nowlin et al. | Aug 2011 | B2 |
8010177 | Csavoy et al. | Aug 2011 | B2 |
8019045 | Kato | Sep 2011 | B2 |
8021310 | Sanborn et al. | Sep 2011 | B2 |
8035685 | Jensen | Oct 2011 | B2 |
8046054 | Kim et al. | Oct 2011 | B2 |
8046057 | Clarke | Oct 2011 | B2 |
8052688 | Wolf, II | Nov 2011 | B2 |
8054184 | Cline et al. | Nov 2011 | B2 |
8054752 | Druke et al. | Nov 2011 | B2 |
8057397 | Li et al. | Nov 2011 | B2 |
8057407 | Martinelli et al. | Nov 2011 | B2 |
8062288 | Cooper et al. | Nov 2011 | B2 |
8062375 | Glerum et al. | Nov 2011 | B2 |
8066524 | Burbank et al. | Nov 2011 | B2 |
8073335 | Labonville et al. | Dec 2011 | B2 |
8079950 | Stern et al. | Dec 2011 | B2 |
8086299 | Adler et al. | Dec 2011 | B2 |
8092370 | Roberts et al. | Jan 2012 | B2 |
8098914 | Liao et al. | Jan 2012 | B2 |
8100950 | St. Clair et al. | Jan 2012 | B2 |
8105320 | Manzo | Jan 2012 | B2 |
8108025 | Csavoy et al. | Jan 2012 | B2 |
8109877 | Moctezuma de la Barrera et al. | Feb 2012 | B2 |
8112292 | Simon | Feb 2012 | B2 |
8116430 | Shapiro et al. | Feb 2012 | B1 |
8120301 | Goldberg et al. | Feb 2012 | B2 |
8121249 | Wang et al. | Feb 2012 | B2 |
8123675 | Funda et al. | Feb 2012 | B2 |
8133229 | Bonutti | Mar 2012 | B1 |
8142420 | Schena | Mar 2012 | B2 |
8147494 | Leitner et al. | Apr 2012 | B2 |
8150494 | Simon et al. | Apr 2012 | B2 |
8150497 | Gielen et al. | Apr 2012 | B2 |
8150498 | Gielen et al. | Apr 2012 | B2 |
8165658 | Waynik et al. | Apr 2012 | B2 |
8170313 | Kendrick et al. | May 2012 | B2 |
8179073 | Farritor et al. | May 2012 | B2 |
8182476 | Julian et al. | May 2012 | B2 |
8184880 | Zhao et al. | May 2012 | B2 |
8202278 | Orban, III et al. | Jun 2012 | B2 |
8208708 | Homan et al. | Jun 2012 | B2 |
8208988 | Jenser | Jun 2012 | B2 |
8219177 | Smith et al. | Jul 2012 | B2 |
8219178 | Smith et al. | Jul 2012 | B2 |
8220468 | Cooper et al. | Jul 2012 | B2 |
8224024 | Foxlin et al. | Jul 2012 | B2 |
8224484 | Swarup et al. | Jul 2012 | B2 |
8225798 | Baldwin et al. | Jul 2012 | B2 |
8228368 | Zhao et al. | Jul 2012 | B2 |
8231610 | Jo et al. | Jul 2012 | B2 |
8263933 | Hartmann et al. | Jul 2012 | B2 |
8239001 | Verard et al. | Aug 2012 | B2 |
8241271 | Millman et al. | Aug 2012 | B2 |
8248413 | Gattani et al. | Aug 2012 | B2 |
8256319 | Cooper et al. | Sep 2012 | B2 |
8271069 | Jascob et al. | Sep 2012 | B2 |
8271130 | Hourtash | Sep 2012 | B2 |
8281670 | Larkin et al. | Oct 2012 | B2 |
8282653 | Nelson et al. | Oct 2012 | B2 |
8301226 | Csavoy et al. | Oct 2012 | B2 |
8311611 | Csavoy et al. | Nov 2012 | B2 |
8320991 | Jascob et al. | Nov 2012 | B2 |
8332012 | Kienzle, III | Dec 2012 | B2 |
8333755 | Cooper et al. | Dec 2012 | B2 |
8335552 | Stiles | Dec 2012 | B2 |
8335557 | Maschke | Dec 2012 | B2 |
8348931 | Cooper et al. | Jan 2013 | B2 |
8353963 | Glerum | Jan 2013 | B2 |
8358818 | Miga et al. | Jan 2013 | B2 |
8359730 | Burg et al. | Jan 2013 | B2 |
8374673 | Adcox et al. | Feb 2013 | B2 |
8374723 | Zhao et al. | Feb 2013 | B2 |
8379791 | Forthmann et al. | Feb 2013 | B2 |
8386019 | Camus et al. | Feb 2013 | B2 |
8392022 | Ortmaier et al. | Mar 2013 | B2 |
8394099 | Patwardhan | Mar 2013 | B2 |
8395342 | Prisco | Mar 2013 | B2 |
8398634 | Manzo et al. | Mar 2013 | B2 |
8400094 | Schena | Mar 2013 | B2 |
8414957 | Enzerink et al. | Apr 2013 | B2 |
8418073 | Mohr et al. | Apr 2013 | B2 |
8450694 | Baviera et al. | May 2013 | B2 |
8452447 | Nixon | May 2013 | B2 |
RE44305 | Foley et al. | Jun 2013 | E |
8462911 | Vesel et al. | Jun 2013 | B2 |
8465476 | Rogers et al. | Jun 2013 | B2 |
8465771 | Wan et al. | Jun 2013 | B2 |
8467851 | Mire et al. | Jun 2013 | B2 |
8467852 | Csavoy et al. | Jun 2013 | B2 |
8469947 | Devengenzo et al. | Jun 2013 | B2 |
RE44392 | Hynes | Jul 2013 | E |
8483434 | Buehner et al. | Jul 2013 | B2 |
8483800 | Jensen et al. | Jul 2013 | B2 |
8486532 | Enzerink et al. | Jul 2013 | B2 |
8489235 | Moll et al. | Jul 2013 | B2 |
8500722 | Cooper | Aug 2013 | B2 |
8500728 | Newton et al. | Aug 2013 | B2 |
8504201 | Moll et al. | Aug 2013 | B2 |
8506555 | Ruiz Morales | Aug 2013 | B2 |
8506556 | Schena | Aug 2013 | B2 |
8508173 | Goldberg et al. | Aug 2013 | B2 |
8512318 | Tovey et al. | Aug 2013 | B2 |
8515576 | Lipow et al. | Aug 2013 | B2 |
8518120 | Glerum et al. | Aug 2013 | B2 |
8521331 | Itkowitz | Aug 2013 | B2 |
8526688 | Groszmann et al. | Sep 2013 | B2 |
8526700 | Issacs | Sep 2013 | B2 |
8527094 | Kumar et al. | Sep 2013 | B2 |
8528440 | Morley et al. | Sep 2013 | B2 |
8532741 | Heruth et al. | Sep 2013 | B2 |
8541970 | Nowlin et al. | Sep 2013 | B2 |
8548563 | Simon et al. | Oct 2013 | B2 |
8549732 | Burg et al. | Oct 2013 | B2 |
8551114 | Ramos de la Pena | Oct 2013 | B2 |
8551116 | Julian et al. | Oct 2013 | B2 |
8556807 | Scott et al. | Oct 2013 | B2 |
8556979 | Glerum et al. | Oct 2013 | B2 |
8560118 | Green et al. | Oct 2013 | B2 |
8561473 | Blumenkranz | Oct 2013 | B2 |
8562594 | Cooper et al. | Oct 2013 | B2 |
8571638 | Shoham | Oct 2013 | B2 |
8571710 | Coste-Maniere et al. | Oct 2013 | B2 |
8573465 | Shelton, IV | Nov 2013 | B2 |
8574303 | Sharkey et al. | Nov 2013 | B2 |
8585420 | Burbank et al. | Nov 2013 | B2 |
8594841 | Zhao et al. | Nov 2013 | B2 |
8597198 | Sanborn et al. | Dec 2013 | B2 |
8600478 | Verard et al. | Dec 2013 | B2 |
8603077 | Cooper et al. | Dec 2013 | B2 |
8611985 | Lavallee et al. | Dec 2013 | B2 |
8613230 | Blumenkranz et al. | Dec 2013 | B2 |
8621939 | Blumenkranz et al. | Jan 2014 | B2 |
8624537 | Nowlin et al. | Jan 2014 | B2 |
8630389 | Kato | Jan 2014 | B2 |
8634897 | Simon et al. | Jan 2014 | B2 |
8634957 | Toth et al. | Jan 2014 | B2 |
8638056 | Goldberg et al. | Jan 2014 | B2 |
8638057 | Goldberg et al. | Jan 2014 | B2 |
8639000 | Zhao et al. | Jan 2014 | B2 |
8641726 | Bonutti | Feb 2014 | B2 |
8644907 | Hartmann et al. | Feb 2014 | B2 |
8657809 | Schoepp | Feb 2014 | B2 |
8660635 | Simon et al. | Feb 2014 | B2 |
8666544 | Moll et al. | Mar 2014 | B2 |
8675939 | Moctezuma de la Barrera | Mar 2014 | B2 |
8678647 | Gregerson et al. | Mar 2014 | B2 |
8679125 | Smith et al. | Mar 2014 | B2 |
8679183 | Glerum et al. | Mar 2014 | B2 |
8682413 | Lloyd | Mar 2014 | B2 |
8684253 | Giordano et al. | Apr 2014 | B2 |
8685098 | Glerum et al. | Apr 2014 | B2 |
8693730 | Umasuthan et al. | Apr 2014 | B2 |
8694075 | Groszmann et al. | Apr 2014 | B2 |
8696458 | Foxlin et al. | Apr 2014 | B2 |
8700123 | Okamura et al. | Apr 2014 | B2 |
8706086 | Glerum | Apr 2014 | B2 |
8706185 | Foley et al. | Apr 2014 | B2 |
8706301 | Zhao et al. | Apr 2014 | B2 |
8717430 | Simon et al. | May 2014 | B2 |
8727618 | Maschke et al. | May 2014 | B2 |
8734432 | Tuma et al. | May 2014 | B2 |
8738115 | Amberg et al. | May 2014 | B2 |
8738181 | Greer et al. | May 2014 | B2 |
8740882 | Jun et al. | Jun 2014 | B2 |
8746252 | McGrogan et al. | Jun 2014 | B2 |
8749189 | Nowlin et al. | Jun 2014 | B2 |
8749190 | Nowlin et al. | Jun 2014 | B2 |
8761930 | Nixon | Jun 2014 | B2 |
8764448 | Yang et al. | Jul 2014 | B2 |
8771170 | Mesallum et al. | Jul 2014 | B2 |
8781186 | Clements et al. | Jul 2014 | B2 |
8781630 | Banks et al. | Jul 2014 | B2 |
8784385 | Boyden et al. | Jul 2014 | B2 |
8786241 | Nowlin et al. | Jul 2014 | B2 |
8787520 | Baba | Jul 2014 | B2 |
8792704 | Isaacs | Jul 2014 | B2 |
8798231 | Notohara et al. | Aug 2014 | B2 |
8800838 | Shelton, IV | Aug 2014 | B2 |
8808164 | Hoffman et al. | Aug 2014 | B2 |
8812077 | Dempsey | Aug 2014 | B2 |
8814793 | Brabrand | Aug 2014 | B2 |
8816628 | Nowlin et al. | Aug 2014 | B2 |
8818105 | Myronenko et al. | Aug 2014 | B2 |
8820605 | Shelton, IV | Sep 2014 | B2 |
8821511 | von Jako et al. | Sep 2014 | B2 |
8823308 | Nowlin et al. | Sep 2014 | B2 |
8827996 | Scott et al. | Sep 2014 | B2 |
8828024 | Farritor et al. | Sep 2014 | B2 |
8830224 | Zhao et al. | Sep 2014 | B2 |
8834489 | Cooper et al. | Sep 2014 | B2 |
8834490 | Bonutti | Sep 2014 | B2 |
8838270 | Druke et al. | Sep 2014 | B2 |
8844789 | Shelton, IV et al. | Sep 2014 | B2 |
8855822 | Bartol et al. | Oct 2014 | B2 |
8858598 | Seifert et al. | Oct 2014 | B2 |
8860753 | Bhandarkar et al. | Oct 2014 | B2 |
8864751 | Prisco et al. | Oct 2014 | B2 |
8864798 | Weiman et al. | Oct 2014 | B2 |
8864833 | Glerum et al. | Oct 2014 | B2 |
8867703 | Shapiro et al. | Oct 2014 | B2 |
8870880 | Himmelberger et al. | Oct 2014 | B2 |
8876866 | Zappacosta et al. | Nov 2014 | B2 |
8880223 | Raj et al. | Nov 2014 | B2 |
8882803 | Iott et al. | Nov 2014 | B2 |
8883210 | Truncale et al. | Nov 2014 | B1 |
8888821 | Rezach et al. | Nov 2014 | B2 |
8888853 | Glerum et al. | Nov 2014 | B2 |
8888854 | Glerum et al. | Nov 2014 | B2 |
8894652 | Seifert et al. | Nov 2014 | B2 |
8894688 | Suh | Nov 2014 | B2 |
8894691 | Iott et al. | Nov 2014 | B2 |
8906069 | Hansell et al. | Dec 2014 | B2 |
8964934 | Ein-Gal | Feb 2015 | B2 |
8992580 | Bar et al. | Mar 2015 | B2 |
8996169 | Lightcap et al. | Mar 2015 | B2 |
9001963 | Sowards-Emmerd et al. | Apr 2015 | B2 |
9002076 | Khadem et al. | Apr 2015 | B2 |
9044190 | Rubner et al. | Jun 2015 | B2 |
9107683 | Hourtash et al. | Aug 2015 | B2 |
9125556 | Zehavi et al. | Sep 2015 | B2 |
9131986 | Greer et al. | Sep 2015 | B2 |
9215968 | Schostek et al. | Dec 2015 | B2 |
9308050 | Kostrzewski et al. | Apr 2016 | B2 |
9380984 | Li et al. | Jul 2016 | B2 |
9393039 | Lechner et al. | Jul 2016 | B2 |
9398886 | Gregerson et al. | Jul 2016 | B2 |
9398890 | Dong et al. | Jul 2016 | B2 |
9414859 | Ballard et al. | Aug 2016 | B2 |
9420975 | Gutfleisch et al. | Aug 2016 | B2 |
9492235 | Hourtash et al. | Nov 2016 | B2 |
9592096 | Maillet et al. | Mar 2017 | B2 |
9750465 | Engel et al. | Sep 2017 | B2 |
9757203 | Hourtash et al. | Sep 2017 | B2 |
9795354 | Menegaz et al. | Oct 2017 | B2 |
9814535 | Bar et al. | Nov 2017 | B2 |
9820783 | Donner et al. | Nov 2017 | B2 |
9833265 | Donner et al. | Nov 2017 | B2 |
9848922 | Tohmeh et al. | Dec 2017 | B2 |
9925011 | Gombert et al. | Mar 2018 | B2 |
9931025 | Graetzel et al. | Apr 2018 | B1 |
10034717 | Miller et al. | Jul 2018 | B2 |
20010036302 | Miller | Nov 2001 | A1 |
20020035321 | Bucholz et al. | Mar 2002 | A1 |
20040068172 | Nowinski et al. | Apr 2004 | A1 |
20040076259 | Jensen et al. | Apr 2004 | A1 |
20050096502 | Khalili | May 2005 | A1 |
20050143651 | Verard et al. | Jun 2005 | A1 |
20050171558 | Abovitz et al. | Aug 2005 | A1 |
20060100610 | Wallace et al. | May 2006 | A1 |
20060173329 | Marquart et al. | Aug 2006 | A1 |
20060184396 | Dennis et al. | Aug 2006 | A1 |
20060241416 | Marquart et al. | Oct 2006 | A1 |
20060291612 | Nishide et al. | Dec 2006 | A1 |
20070015987 | Benlloch Baviera et al. | Jan 2007 | A1 |
20070021738 | Hasser et al. | Jan 2007 | A1 |
20070038059 | Sheffer et al. | Feb 2007 | A1 |
20070073133 | Schoenefeld | Mar 2007 | A1 |
20070156121 | Millman et al. | Jul 2007 | A1 |
20070156157 | Nahum et al. | Jul 2007 | A1 |
20070167712 | Keglovich et al. | Jul 2007 | A1 |
20070233238 | Huynh et al. | Oct 2007 | A1 |
20080004523 | Jensen | Jan 2008 | A1 |
20080013809 | Zhu et al. | Jan 2008 | A1 |
20080033283 | Dellaca et al. | Feb 2008 | A1 |
20080046122 | Manzo et al. | Feb 2008 | A1 |
20080082109 | Moll et al. | Apr 2008 | A1 |
20080108912 | Node-Langlois | May 2008 | A1 |
20080108991 | von Jako | May 2008 | A1 |
20080109012 | Falco et al. | May 2008 | A1 |
20080144906 | Allred et al. | Jun 2008 | A1 |
20080161680 | von Jako et al. | Jul 2008 | A1 |
20080161682 | Kendrick et al. | Jul 2008 | A1 |
20080177203 | von Jako | Jul 2008 | A1 |
20080214922 | Hartmann et al. | Sep 2008 | A1 |
20080228068 | Viswanathan et al. | Sep 2008 | A1 |
20080228196 | Wang et al. | Sep 2008 | A1 |
20080235052 | Node-Langlois et al. | Sep 2008 | A1 |
20080269596 | Revie et al. | Oct 2008 | A1 |
20080287771 | Anderson | Nov 2008 | A1 |
20080287781 | Revie et al. | Nov 2008 | A1 |
20080300477 | Lloyd et al. | Dec 2008 | A1 |
20080300478 | Zuhars et al. | Dec 2008 | A1 |
20080302950 | Park et al. | Dec 2008 | A1 |
20080306490 | Lakin et al. | Dec 2008 | A1 |
20080319311 | Hamadeh | Dec 2008 | A1 |
20090012509 | Csavoy et al. | Jan 2009 | A1 |
20090030428 | Omori et al. | Jan 2009 | A1 |
20090080737 | Battle et al. | Mar 2009 | A1 |
20090185655 | Koken et al. | Jul 2009 | A1 |
20090198121 | Hoheisel | Aug 2009 | A1 |
20090216113 | Meier et al. | Aug 2009 | A1 |
20090228019 | Gross et al. | Sep 2009 | A1 |
20090259123 | Navab et al. | Oct 2009 | A1 |
20090259230 | Khadem et al. | Oct 2009 | A1 |
20090264899 | Appenrodt et al. | Oct 2009 | A1 |
20090281417 | Hartmann et al. | Nov 2009 | A1 |
20100022874 | Wang et al. | Jan 2010 | A1 |
20100039506 | Sarvestani et al. | Feb 2010 | A1 |
20100125286 | Wang et al. | May 2010 | A1 |
20100130986 | Mailloux et al. | May 2010 | A1 |
20100228117 | Hartmann | Sep 2010 | A1 |
20100228265 | Prisco | Sep 2010 | A1 |
20100249571 | Jensen et al. | Sep 2010 | A1 |
20100274120 | Heuscher | Oct 2010 | A1 |
20100280363 | Skarda et al. | Nov 2010 | A1 |
20100331858 | Simaan et al. | Dec 2010 | A1 |
20110022229 | Jang et al. | Jan 2011 | A1 |
20110077504 | Fischer et al. | Mar 2011 | A1 |
20110098553 | Robbins et al. | Apr 2011 | A1 |
20110137152 | Li | Jun 2011 | A1 |
20110213384 | Jeong | Sep 2011 | A1 |
20110224684 | Larkin et al. | Sep 2011 | A1 |
20110224685 | Larkin et al. | Sep 2011 | A1 |
20110224686 | Larkin et al. | Sep 2011 | A1 |
20110224687 | Larkin et al. | Sep 2011 | A1 |
20110224688 | Larkin et al. | Sep 2011 | A1 |
20110224689 | Larkin et al. | Sep 2011 | A1 |
20110224825 | Larkin et al. | Sep 2011 | A1 |
20110230967 | O'Halloran et al. | Sep 2011 | A1 |
20110238080 | Ranjit et al. | Sep 2011 | A1 |
20110276058 | Choi et al. | Nov 2011 | A1 |
20110282189 | Graumann | Nov 2011 | A1 |
20110286573 | Schretter et al. | Nov 2011 | A1 |
20110295062 | Gratacos Solsona et al. | Dec 2011 | A1 |
20110295370 | Suh et al. | Dec 2011 | A1 |
20110306986 | Lee et al. | Dec 2011 | A1 |
20120035507 | George et al. | Feb 2012 | A1 |
20120046668 | Gantes | Feb 2012 | A1 |
20120051498 | Koishi | Mar 2012 | A1 |
20120053597 | Anvari et al. | Mar 2012 | A1 |
20120059248 | Holsing et al. | Mar 2012 | A1 |
20120071753 | Hunter et al. | Mar 2012 | A1 |
20120108954 | Schulhauser et al. | May 2012 | A1 |
20120136372 | Amat Girbau et al. | May 2012 | A1 |
20120143084 | Shoham | Jun 2012 | A1 |
20120184839 | Woerlein | Jul 2012 | A1 |
20120197182 | Millman et al. | Aug 2012 | A1 |
20120226145 | Chang et al. | Sep 2012 | A1 |
20120235909 | Birkenbach et al. | Sep 2012 | A1 |
20120245596 | Meenink | Sep 2012 | A1 |
20120253332 | Moll | Oct 2012 | A1 |
20120253360 | White et al. | Oct 2012 | A1 |
20120256092 | Zingerman | Oct 2012 | A1 |
20120294498 | Popovic | Nov 2012 | A1 |
20120296203 | Hartmann et al. | Nov 2012 | A1 |
20130006267 | Odermatt et al. | Jan 2013 | A1 |
20130016889 | Myronenko et al. | Jan 2013 | A1 |
20130030571 | Ruiz Morales et al. | Jan 2013 | A1 |
20130035583 | Park et al. | Feb 2013 | A1 |
20130060146 | Yang et al. | Mar 2013 | A1 |
20130060337 | Petersheim et al. | Mar 2013 | A1 |
20130094742 | Feilkas | Apr 2013 | A1 |
20130096574 | Kang et al. | Apr 2013 | A1 |
20130113791 | Isaacs et al. | May 2013 | A1 |
20130116706 | Lee et al. | May 2013 | A1 |
20130131695 | Scarfogliero et al. | May 2013 | A1 |
20130144307 | Jeong et al. | Jun 2013 | A1 |
20130158542 | Manzo et al. | Jun 2013 | A1 |
20130165937 | Patwardhan | Jun 2013 | A1 |
20130178867 | Farritor et al. | Jul 2013 | A1 |
20130178868 | Roh | Jul 2013 | A1 |
20130178870 | Schena | Jul 2013 | A1 |
20130204271 | Brisson et al. | Aug 2013 | A1 |
20130211419 | Jensen | Aug 2013 | A1 |
20130211420 | Jensen | Aug 2013 | A1 |
20130218142 | Tuma et al. | Aug 2013 | A1 |
20130223702 | Holsing et al. | Aug 2013 | A1 |
20130225942 | Holsing et al. | Aug 2013 | A1 |
20130225943 | Holsing et al. | Aug 2013 | A1 |
20130231556 | Holsing et al. | Sep 2013 | A1 |
20130237995 | Lee et al. | Sep 2013 | A1 |
20130245375 | DiMaio et al. | Sep 2013 | A1 |
20130261640 | Kim et al. | Oct 2013 | A1 |
20130272488 | Bailey et al. | Oct 2013 | A1 |
20130272489 | Dickman et al. | Oct 2013 | A1 |
20130274761 | Devengenzo et al. | Oct 2013 | A1 |
20130281821 | Liu et al. | Oct 2013 | A1 |
20130296884 | Taylor et al. | Nov 2013 | A1 |
20130303887 | Holsing et al. | Nov 2013 | A1 |
20130307955 | Deitz et al. | Nov 2013 | A1 |
20130317521 | Choi et al. | Nov 2013 | A1 |
20130325033 | Schena et al. | Dec 2013 | A1 |
20130325035 | Hauck et al. | Dec 2013 | A1 |
20130331686 | Freysinger et al. | Dec 2013 | A1 |
20130331858 | Devengenzo et al. | Dec 2013 | A1 |
20130331861 | Yoon | Dec 2013 | A1 |
20130342578 | Isaacs | Dec 2013 | A1 |
20130345717 | Markvicka et al. | Dec 2013 | A1 |
20130345757 | Stad | Dec 2013 | A1 |
20140001235 | Shelton, IV | Jan 2014 | A1 |
20140012131 | Heruth et al. | Jan 2014 | A1 |
20140031664 | Kang et al. | Jan 2014 | A1 |
20140046128 | Lee et al. | Feb 2014 | A1 |
20140046132 | Hoeg et al. | Feb 2014 | A1 |
20140046340 | Wilson et al. | Feb 2014 | A1 |
20140049629 | Siewerdsen et al. | Feb 2014 | A1 |
20140058406 | Tsekos | Feb 2014 | A1 |
20140073914 | Lavallee et al. | Mar 2014 | A1 |
20140080086 | Chen | Mar 2014 | A1 |
20140081128 | Verard et al. | Mar 2014 | A1 |
20140088612 | Bartol et al. | Mar 2014 | A1 |
20140094694 | Moctezuma de la Barrera | Apr 2014 | A1 |
20140094851 | Gordon | Apr 2014 | A1 |
20140096369 | Matsumoto et al. | Apr 2014 | A1 |
20140100587 | Farritor et al. | Apr 2014 | A1 |
20140121676 | Kostrzewski et al. | May 2014 | A1 |
20140128882 | Kwak et al. | May 2014 | A1 |
20140135796 | Simon et al. | May 2014 | A1 |
20140142591 | Alvarez et al. | May 2014 | A1 |
20140142592 | Moon et al. | May 2014 | A1 |
20140148692 | Hartmann et al. | May 2014 | A1 |
20140163581 | Devengenzo et al. | Jun 2014 | A1 |
20140171781 | Stiles | Jun 2014 | A1 |
20140171900 | Stiles | Jun 2014 | A1 |
20140171965 | Loh et al. | Jun 2014 | A1 |
20140180308 | von Grunberg | Jun 2014 | A1 |
20140180309 | Seeber et al. | Jun 2014 | A1 |
20140187915 | Yaroshenko et al. | Jul 2014 | A1 |
20140188132 | Kang | Jul 2014 | A1 |
20140194699 | Roh et al. | Jul 2014 | A1 |
20140130810 | Azizian et al. | Aug 2014 | A1 |
20140221819 | Sarment | Aug 2014 | A1 |
20140222023 | Kim et al. | Aug 2014 | A1 |
20140228631 | Kwak et al. | Aug 2014 | A1 |
20140234804 | Huang et al. | Aug 2014 | A1 |
20140257328 | Kim et al. | Sep 2014 | A1 |
20140257329 | Jang et al. | Sep 2014 | A1 |
20140257330 | Choi et al. | Sep 2014 | A1 |
20140275760 | Lee et al. | Sep 2014 | A1 |
20140275985 | Walker et al. | Sep 2014 | A1 |
20140276931 | Parihar et al. | Sep 2014 | A1 |
20140276940 | Seo | Sep 2014 | A1 |
20140276944 | Farritor et al. | Sep 2014 | A1 |
20140288413 | Hwang et al. | Sep 2014 | A1 |
20140299648 | Shelton, IV et al. | Oct 2014 | A1 |
20140303434 | Farritor et al. | Oct 2014 | A1 |
20140303643 | Ha et al. | Oct 2014 | A1 |
20140305995 | Shelton, IV et al. | Oct 2014 | A1 |
20140309659 | Roh et al. | Oct 2014 | A1 |
20140316436 | Bar et al. | Oct 2014 | A1 |
20140323803 | Hoffman et al. | Oct 2014 | A1 |
20140324070 | Min et al. | Oct 2014 | A1 |
20140330288 | Date et al. | Nov 2014 | A1 |
20140364720 | Darrow et al. | Dec 2014 | A1 |
20140371577 | Maillet et al. | Dec 2014 | A1 |
20150039034 | Frankel et al. | Feb 2015 | A1 |
20150085970 | Bouhnik et al. | Mar 2015 | A1 |
20150146847 | Liu | May 2015 | A1 |
20150150524 | Yorkston et al. | Jun 2015 | A1 |
20150196261 | Funk | Jul 2015 | A1 |
20150213633 | Chang et al. | Jul 2015 | A1 |
20150335480 | Alvarez et al. | Nov 2015 | A1 |
20150342647 | Frankel et al. | Dec 2015 | A1 |
20160005194 | Schretter et al. | Jan 2016 | A1 |
20160166329 | Langan et al. | Jun 2016 | A1 |
20160235480 | Scholl et al. | Aug 2016 | A1 |
20160249990 | Glozman et al. | Sep 2016 | A1 |
20160302871 | Gregerson et al. | Oct 2016 | A1 |
20160320322 | Suzuki | Nov 2016 | A1 |
20160331335 | Gregerson et al. | Nov 2016 | A1 |
20170135770 | Scholl et al. | May 2017 | A1 |
20170143284 | Sehnert et al. | May 2017 | A1 |
20170143426 | Isaacs et al. | May 2017 | A1 |
20170156816 | Ibrahim | Jun 2017 | A1 |
20170202629 | Maillet et al. | Jul 2017 | A1 |
20170212723 | Atarot et al. | Jul 2017 | A1 |
20170215825 | Johnson et al. | Aug 2017 | A1 |
20170215826 | Johnson et al. | Aug 2017 | A1 |
20170215827 | Johnson et al. | Aug 2017 | A1 |
20170231710 | Scholl et al. | Aug 2017 | A1 |
20170258426 | Risher-Kelly et al. | Sep 2017 | A1 |
20170273748 | Hourtash et al. | Sep 2017 | A1 |
20170296277 | Hourtash et al. | Oct 2017 | A1 |
20170360493 | Zucher et al. | Dec 2017 | A1 |
Entry |
---|
US 8,231,638 B2, 07/2012, Swarup et al. (withdrawn) |
Number | Date | Country | |
---|---|---|---|
20230310086 A1 | Oct 2023 | US |